Skip to content

Phathom Pharmaceuticals, Inc. PHAT Loss on Debt Extinguishment

Loss on Debt Extinguishment at other companies

Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
-$2.76M
PVL
Palvella TherapeuticsPVLA
$0-100%
Roivant Sciences logo
Roivant SciencesROIV
$0+100%

Other financials

Income statement

See full
Revenue$58.3M+104%
Gross profit$46.3M+86.8%
Operating income-$15.5M+80.4%
Net income-$30.4M+67.8%
EPS (diluted)-$0.37+71.8%

Balance sheet

See full
Cash & equivalents$180.9M-14.8%
Total debt$166.3M-18.3%
Total equity-$337.0M+0.4%
Total assets$305.1M+3.7%

Cash flow

See full
Operating cash flow-$15.6M+81.6%
CapEx$61.0K+239%
Free cash flow-$15.7M+81.5%

Valuation

See full
Market cap$824.68M+13.4%
Enterprise value$810.08M+12.7%
P/S-4.9×

Profitability

See full
Gross margin84.9%-1.3pp
Operating margin-47.1%-21.9pp
Net margin-76.8%-34.5pp
FCF margin-47.7%-22.1pp

Returns & leverage

See full
Return on equity-147.9%
Debt / equity5.6×
Current ratio2.2×-1.4×

Where this comes from

Reported directly by Phathom Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:GainsLossesOnExtinguishmentOfDebt.

The official record: Phathom Pharmaceuticals, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Phathom Pharmaceuticals, Inc.'s loss on debt extinguishment.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Phathom Pharmaceuticals, Inc.'s loss on debt extinguishment?
Phathom Pharmaceuticals, Inc. (PHAT) reported loss on debt extinguishment of -$829K in Q1 2026.
What does loss on debt extinguishment mean?
Non-cash loss from retiring debt before maturity, added back in operating cash flow since the cash impact is in financing.